115 related articles for article (PubMed ID: 2298190)
21. Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration.
van Duijkeren E; Vulto AG; Sloet van Oldruitenborgh-Oosterbaan MM; Kessels BG; van Miert AS; Breukink HJ
J Vet Pharmacol Ther; 1995 Feb; 18(1):47-53. PubMed ID: 7752306
[TBL] [Abstract][Full Text] [Related]
22. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
Richards DA
J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
Bodemar G; Norlander B; Walan A
Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
[TBL] [Abstract][Full Text] [Related]
26. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
28. Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children.
Martyn JA; Greenblatt DJ; Hagen J; Hoaglin DC
Eur J Clin Pharmacol; 1989; 36(4):361-7. PubMed ID: 2737228
[TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tinidazole in the horse.
Pyörälä S; Kotilainen T; Silvennoinen P; Hänninen U; Mero M; Kaartinen L
J Vet Pharmacol Ther; 1990 Mar; 13(1):76-80. PubMed ID: 2319639
[TBL] [Abstract][Full Text] [Related]
31. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.
Mummaneni V; Amidon GL; Dressman JB
Pharm Res; 1995 May; 12(5):780-6. PubMed ID: 7479568
[TBL] [Abstract][Full Text] [Related]
32. Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration.
Haddad NS; Pedersoli WM; Ravis WR; Fazeli MH; Carson RL
Am J Vet Res; 1985 Sep; 46(9):2004-7. PubMed ID: 4051305
[TBL] [Abstract][Full Text] [Related]
33. Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
Barbhaiya RH; Shukla UA; Greene DS
Br J Clin Pharmacol; 1995 Aug; 40(2):161-5. PubMed ID: 8562300
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects.
Dimmitt DC; Cramer MB; Keung A; Arumugham T; Weir SJ
Cancer Chemother Pharmacol; 1999; 43(2):126-32. PubMed ID: 9923817
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of clemastine in healthy horses.
Törneke K; Ingvast-Larsson C; Pettersson K; Bergvall K; Hedeland M; Bondesson U; Broström H
J Vet Pharmacol Ther; 2003 Apr; 26(2):151-7. PubMed ID: 12667185
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
[TBL] [Abstract][Full Text] [Related]
37. A pharmacokinetic study of digoxin in the horse.
Brumbaugh GW; Thomas WP; Enos LR; Kaneko JJ
J Vet Pharmacol Ther; 1983 Sep; 6(3):163-72. PubMed ID: 6632073
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of ascorbic acid in horses.
Löscher W; Jaeschke G; Keller H
Equine Vet J; 1984 Jan; 16(1):59-65. PubMed ID: 6714208
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of metronidazole given to horses by intravenous and oral routes.
Sweeney RW; Sweeney CR; Soma LR; Woodward CB; Charlton CA
Am J Vet Res; 1986 Aug; 47(8):1726-9. PubMed ID: 3752681
[TBL] [Abstract][Full Text] [Related]
40. Influences of cigarette smoke inhalation on pharmacokinetics of cimetidine in rats.
Eto K; Gomita Y; Furuno K; Yao K; Moriyama M; Araki Y
Drug Metabol Drug Interact; 1991; 9(2):103-14. PubMed ID: 1800017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
